drugset / Trial / NCT03030664

Effect of L. Reuteri on Bowel Movements in Children (BIOWELL Study)

NCT03030664

RandomizedParallel-groupTriple-blindTreatment

Summary

A randomized, multicenter, placebo-controlled, double blind study in two parallel groups testing the efficacy of daily oral supplementation with the probiotic L.reuteri DSM17938 compared to placebo in increasing the number of spontaneous bowel movements in infants and children with functional constipation.

Timeline

Start
2017-03-01
Primary completion
2021-06-30
Completion
2021-07-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactobacillus reuteri Other / unclassified 1e+08 unknown Oral

Indications